- Filed
- Mar 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Mar 15, 2024 | 511.11M sh |
| Capex | FY 2023 · Dec 31, 2023 | $16K |
| Shares Diluted | FY 2023 · Dec 31, 2022 | 212.48M sh |
| Operating Cash Flow restated | FY 2023 · Dec 31, 2022 | −$9.4M |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $15.52M |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $351K |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $1.93M |
| Current Assets | FY 2023 · Dec 31, 2022 | $17.98M |
| Total Assets | FY 2023 · Dec 31, 2022 | $18.87M |
| Eps Diluted | FY 2023 · Dec 31, 2022 | −$0.04 |
| Eps Basic | FY 2023 · Dec 31, 2022 | −$0.04 |
| Sga Expense restated | FY 2023 · Dec 31, 2022 | $5.11M |
| Net Income | FY 2023 · Dec 31, 2022 | −$9.43M |
| Stockholders Equity | FY 2023 · Dec 31, 2021 | $23.44M |